Operating Lease, Payments of Protalix BioTherapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Protalix BioTherapeutics, Inc. quarterly and annual Operating Lease, Payments in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Protalix BioTherapeutics, Inc. Operating Lease, Payments for the quarter ending 30 Sep 2025 was $457,000, a 11% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Operating Lease, Payments for 2024 was $1,634,000, a 10% increase from 2023.
  • Protalix BioTherapeutics, Inc. annual Operating Lease, Payments for 2023 was $1,484,000, a 5.7% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Operating Lease, Payments for 2022 was $1,404,000, a 0.94% increase from 2021.
Source SEC data
View on sec.gov
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Protalix BioTherapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $457,000 +$44,000 +11% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $413,000 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q4 2019 $1,329,000 $2,000 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
Q3 2019 $337,000 01 Jul 2019 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $662,000 01 Apr 2019 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $328,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2019 2019 Q1

Protalix BioTherapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,634,000 +$150,000 +10% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $1,484,000 +$80,000 +5.7% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $1,404,000 +$13,000 +0.94% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
2021 $1,391,000 +$102,000 +7.9% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $1,289,000 -$40,000 -3% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $1,329,000 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.